Did Smoore International's Fall Catch You Out? What Investors Missed
Summary
Smoore International's stock has fallen 36.3% over the past year, leaving holders of the bullish thesis nursing losses. The article contrasts two narratives: a bullish case that set fair value at HK$24.99 based on aligned incentives, automation and a global shift toward reduced-risk products, and a bearish case that set fair value at HK$9.21 citing stricter US and European vaping regulation, heavy dependence on a few large customers, and rising competition. Smoore's H1 2026 results showed revenue of C¥7,208.88m and net income of C¥571.92m, but net margin slipped from 8.2% to 7.9%, leaving the promised efficiency gains unproven. News that the controlling shareholder plans to cut its stake also challenged the alignment story. The selected narrative's fair value still sits above the current HK$9.25 price, so buyers must now believe Smoore can keep product performance and brand engagement intact while ownership and governance adjust around the proposed EVE Battery Investment stake reduction. The article's broader lesson is that any thesis built on aligned incentives and margin expansion must be tested against ownership changes and net margin in every results release.
(Source:Simply Wall Street)